Oxygen cost of exercise is increased in heart failure after accounting for recovery costs.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 12907545)

Published in Chest on August 01, 2003

Authors

Steven H Mitchell1, Natalie P Steele, Kenneth M Leclerc, Mark Sullivan, Wayne C Levy

Author Affiliations

1: Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, 98195, USA.

Articles by these authors

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 3.86

Exclusion of a luminous red giant as a companion star to the progenitor of supernova SN 2011fe. Nature (2011) 3.62

Supernova SN 2011fe from an exploding carbon-oxygen white dwarf star. Nature (2011) 3.29

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol (2011) 3.25

Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation (2012) 3.24

Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain (2007) 3.07

Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA (2008) 3.01

Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry (2002) 2.86

The type Ia supernova SNLS-03D3bb from a super-Chandrasekhar-mass white dwarf star. Nature (2006) 2.72

Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med (2010) 2.43

Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol (2011) 2.22

Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation (2007) 2.22

Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol (2003) 2.10

Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation (2009) 2.02

Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol (2009) 1.98

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail (2010) 1.96

Temporal and reciprocal relationship between IADL/ADL disability and depressive symptoms in late life. J Gerontol B Psychol Sci Soc Sci (2002) 1.82

Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail (2012) 1.76

The influence of age, gender, and training on exercise efficiency. J Am Coll Cardiol (2006) 1.71

Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome. J Am Stat Assoc (2008) 1.65

Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain (2011) 1.65

Multiple biomarkers for risk prediction in chronic heart failure. Circ Heart Fail (2012) 1.57

Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med (2011) 1.56

Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Med (2007) 1.53

Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol (2012) 1.51

Biomechanical efficiency is impaired in patients with chronic heart failure. Eur J Heart Fail (2007) 1.41

Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model. ASAIO J (2012) 1.39

Superluminous supernovae at redshifts of 2.05 and 3.90. Nature (2012) 1.30

The relationship of attachment style to depression, catastrophizing and health care utilization in patients with chronic pain. Pain (2003) 1.24

Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res (2005) 1.21

Structural genomics of pathogenic protozoa: an overview. Methods Mol Biol (2008) 1.20

trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr (2004) 1.17

Evaluating the ROC performance of markers for future events. Lifetime Data Anal (2007) 1.16

Pain limits the effectiveness of collaborative care for depression. Am J Geriatr Psychiatry (2007) 1.15

Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol (2006) 1.12

Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail (2010) 1.11

Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther (2012) 1.10

Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol (2004) 1.06

Effects of aging on cardiovascular responses to parasympathetic withdrawal. J Am Coll Cardiol (2003) 1.04

The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. J Am Coll Cardiol (2011) 1.04

Research and commentary: Change in exercise tolerance, activity and sleep patterns, and quality of life in patients with cancer participating in a structured exercise program. Oncol Nurs Forum (2003) 1.03

Summary health status measures in advanced heart failure: relationship to clinical variables and outcome. J Card Fail (2007) 1.02

Response styles among patients with minor depression and dysthymia in primary care. J Abnorm Psychol (2002) 1.02

Cytokines in depression and heart failure. Psychosom Med (2003) 1.01

Type IIn supernovae at redshift z approximately 2 from archival data. Nature (2009) 1.01

Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail (2004) 1.01

Feasibility and effectiveness of an automated bilingual text message intervention for weight loss: pilot study. JMIR Res Protoc (2013) 1.01

Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol (2004) 0.99

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer. Mol Cancer Ther (2009) 0.99

Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide. Am J Cardiol (2007) 0.97

Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time. J Am Coll Cardiol (2012) 0.97

Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain. J Adolesc Health (2012) 0.96

Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med (2008) 0.95

Placebos and treatment of pain. Pain Med (2004) 0.95

Predictors of nonresponse to treatment in primary care patients with dysthymia. Gen Hosp Psychiatry (2002) 0.95

Preventing medication errors with smart infusion technology. Am J Health Syst Pharm (2004) 0.95

Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy. BJU Int (2012) 0.94

Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation (2012) 0.93

Safety and efficacy of the MitraClip® system for severe mitral regurgitation: a systematic review. Catheter Cardiovasc Interv (2014) 0.91

Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement. J Heart Lung Transplant (2010) 0.90

APS position statement on the use of placebos in pain management. J Pain (2005) 0.90

Dimethyl sulfoxide (DMSO) exposure to human peripheral blood mononuclear cells (PBMCs) abolish T cell responses only in high concentrations and following coincubation for more than two hours. J Immunol Methods (2010) 0.90

What is the appropriate oxygen tension for in vitro culture? Mol Hum Reprod (2006) 0.89

Trends in the prescription of opioids for adolescents with non-cancer pain. Gen Hosp Psychiatry (2011) 0.89

The effects of atorvastatin (10 mg) on systemic inflammation in heart failure. Am J Cardiol (2005) 0.88

Fatigue, inflammation, and projected mortality in heart failure. J Card Fail (2012) 0.87

The relationship between health risks and health and productivity costs among employees at Pepsi Bottling Group. J Occup Environ Med (2010) 0.87

Exercise training and heart rate variability in older adult female subjects. Clin Invest Med (2006) 0.87

Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod (2006) 0.87

Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure. Am J Cardiol (2005) 0.86

Psychoactive substances and the political ecology of mental distress. Harm Reduct J (2012) 0.86

An intravenous medication safety system: preventing high-risk medication errors at the point of care. J Nurs Adm (2004) 0.86

Correlates of remission in primary care patients treated for minor depression. Gen Hosp Psychiatry (2002) 0.86

Associations between Seattle Heart Failure Model scores and health utilities: findings from HF-ACTION. J Card Fail (2013) 0.86

Drifting in a shrinking future: living with advanced heart failure. J Cardiovasc Nurs (2007) 0.85

Cost-consequences of ultrafiltration for acute heart failure: a decision model analysis. Circ Cardiovasc Qual Outcomes (2009) 0.85

Influence of predictive modeling in implementing optimal heart failure therapy. Am J Med Sci (2011) 0.85

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure. Am Heart J (2010) 0.85

Factors that predict the need for intubation in patients with smoke inhalation injury. Ear Nose Throat J (2006) 0.83

Total Artificial Heart as Bridge to Transplantation for Severe Culture-Negative Prosthetic Valve Endocarditis Due to Gemella haemolysans. ASAIO J (2015) 0.82

In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. J Card Fail (2007) 0.82

Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases. Immunology (2011) 0.82

Multivariate risk scores and patient outcomes in advanced heart failure. Congest Heart Fail (2011) 0.82

Robot-assisted partial nephrectomy: a comparison of the transperitoneal and retroperitoneal approaches. J Endourol (2013) 0.81

Renal cell carcinoma with retro-aortic renal vein thrombus: a case series. BJU Int (2009) 0.81

Potential clinical applications of the HeartMate II risk score. J Am Coll Cardiol (2012) 0.81

Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure. Am J Cardiol (2011) 0.80

An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib. Urol Oncol (2009) 0.80

Biomechanical efficiency is decreased in heart failure during low-level steady state and maximal ramp exercise. Eur J Heart Fail (2004) 0.80

Normal aging impairs upregulation of the beta-adrenergic but not the alpha-adrenergic response: aging and adrenergic upregulation. J Cardiovasc Pharmacol (2006) 0.80

Association between bilirubin and mode of death in severe systolic heart failure. Am J Cardiol (2013) 0.79

Endothelins & erectile dysfunction. Pharmacol Res (2010) 0.79

Empirical support for an evolutionary model of self-destructive motivation. Suicide Life Threat Behav (2009) 0.78

The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV. Nephrol Dial Transplant (2004) 0.78

Comparison of Predicted Exercise Capacity Equations and the Effect of Actual versus Ideal Body Weight among Subjects Undergoing Cardiopulmonary Exercise Testing. Cardiol Res Pract (2013) 0.78

Laparoscopic cytoreductive nephrectomy: a three-center retrospective analysis. J Endourol (2010) 0.78

Re: nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses: C. J. Weight, B. T. Larson, A. F. Fergany, T. Gao, B. R. Lane, S. C. Campbell, J. H. Kaouk, E. A. Klein and A. C. Novick J Urol 2010; 183: 1317-1323. J Urol (2010) 0.77